Grifols S.A.(GRF.MC)— 技术面状态
数据截至2026-10-12 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades +1.8% vs the 50-day and +3.1% vs the 200-day average, 16.9% below the 52-week high and +19.7% off the 52-week low; a golden cross printed 17 sessions ago. Computed from daily closes.
均线状态
- 相对20日均线+3.8%
- 相对50日均线+1.8%
- 相对200日均线+3.1%
- 52周区间低于52周高点16.9% · 高于52周低点19.7%
- 连续走势连续2个交易日上涨
- 均线交叉金叉(17个交易日前)
- 50日均线交叉股价向上穿越50日均线(1个交易日前)
- 随机指标%K 93.5 · %D 75.9(金叉)
相关页面: GRF.MC图表与概览 · 质量与财务体检 · 信号看板
FAQ · from the current data · as of 2026-10-12
Quick answers
GRF.MC当前的Closelook信号是什么?
Bullish stack, 200-day still turning — Trades +1.8% vs the 50-day and +3.1% vs the 200-day average, 16.9% below the 52-week high and +19.7% off the 52-week low; a golden cross printed 17 sessions ago. Computed from daily closes.(截至2026-10-12;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
GRF.MC目前是否位于50日和200日均线上方?
截至2026-10-12,Grifols S.A.位于50日均线上方(+1.8%),200日均线上方(+3.1%);距20日均线+3.8%。
GRF.MC距52周高点有多远?
截至2026-10-12,低于52周高点16.9%,高于52周低点19.7%。
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- NVO Novo Nordisk A/Sindustry
- GSK GlaxoSmithKline PLC ADRindustry
- ABBV AbbVie Incindustry
- BIIB Biogen Incindustry
- GILD Gilead Sciences Incindustry
- PFE Pfizer Incindustry
- MRK Merck & Company Incindustry
- AMGN Amgen Incindustry
- OGN Organon & Coindustry
- JNJ Johnson & Johnsonindustry
- SNY Sanofi ADRindustry
- BMY Bristol-Myers Squibb Companyindustry
- AZN AstraZeneca PLCindustry
- ROVI.MC Laboratorios Farmaceuticos ROVIsector
- ALM.MC Almirall S.A.sector
- HALO Halozyme Therapeutics Incsector